Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

636 ARTÍCULOS , VIENDO DEL 436 AL 450

Medical Management of Movement Disorders

Picillo M, Munhoz RP.

Prog Neurol Surg. 2018;33:41-49. doi: 10.1159/000480747. Epub 2018 Jan 12.

Potassium channel dysfunction in neurons and astrocytes in Huntington's disease

Zhang X, Wan JQ, Tong XP.

CNS Neurosci Ther. 2018 Apr;24(4):311-318. doi: 10.1111/cns.12804. Epub 2018 Jan 27.

A homozygous loss-of-function mutation in PDE2A associated to early-onset hereditary chorea

Salpietro V, Perez-Dueñas B, Nakashima K, San Antonio-Arce V, Manole A, Efthymiou S, Vandrovcova J, Bettencourt C, Mencacci NE, Klein C, Kelly MP, Davies CH, Kimura H, Macaya A, Houlden H.

Mov Disord. 2018 Mar;33(3):482-488. doi: 10.1002/mds.27286. Epub 2018 Feb 2.

Historical perspectives on tardive dyskinesia

Caroff SN, Ungvari GS, Cunningham Owens DG.

J Neurol Sci. 2018 Jun 15;389:4-9. doi: 10.1016/j.jns.2018.02.015. Epub 2018 Feb 3.

Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors

Niemann N, Jankovic J.

Drugs. 2018 Apr;78(5):525-541. doi: 10.1007/s40265-018-0874-x.

Animal models of l-dopa-induced dyskinesia in Parkinson's disease

Cenci MA, Crossman AR.

Mov Disord. 2018 Jul;33(6):889-899. doi: 10.1002/mds.27337. Epub 2018 Feb 28.

Pediatric movement disorders

Badheka R, Barad NK, Sankhla CS.

Neurol India. 2018 Mar-Apr;66(Supplement):S59-S67. doi: 10.4103/0028-3886.226447.

Tardive syndromes

Savitt D, Jankovic J.

J Neurol Sci. 2018 Jun 15;389:35-42. doi: 10.1016/j.jns.2018.02.005. Epub 2018 Feb 5.

Acute hyperkinetic movement disorders in Italian paediatric emergency departments

Raucci U, Parisi P, Vanacore N, Garone G, Bondone C, Palmieri A, Calistri L, Suppiej A, Falsaperla R, Capuano A, Ferro V, Urbino AF, Tallone R, Montemaggi A, Sartori S, Pavone P, Mancardi M, Melani F, Ilvento L, Pelizza MF, Reale A.

Arch Dis Child. 2018 Aug;103(8):790-794. doi: 10.1136/archdischild-2017-314464. Epub 2018 Mar 8.

Paraneoplastic movement disorders

Popławska-Domaszewicz K, Florczak-Wyspiańska J, Kozubski W, Michalak S.

Rev Neurosci. 2018 Sep 25;29(7):745-755. doi: 10.1515/revneuro-2017-0081.

Quality of Life in Huntington's Disease: Critique and Recommendations for Measures Assessing Patient Health-Related Quality of Life and Caregiver Quality of Life

Mestre TA, Carlozzi NE, Ho AK, Burgunder JM, Walker F, Davis AM, Busse M, Quinn L, Rodrigues FB, Sampaio C, Goetz CG, Cubo E, Martinez-Martin P, Stebbins GT; Members of the MDS Committee on Rating Scales Development.

Mov Disord. 2018 May;33(5):742-749. doi: 10.1002/mds.27317. Epub 2018 Mar 23.

Progress in the Diagnosis and Management of Chorea-acanthocytosis

Liu Y, Liu ZY, Wan XH, Guo Y.

Chin Med Sci J. 2018 Mar 30;33(1):53-59. doi: 10.24920/21802.

Rare case of chorea-hyperglycaemia-basal ganglia (C-H-BG) syndrome

Ahmad S, Mohan Babu P, Shenbagaraj L, George L.

BMJ Case Rep. 2018 Apr 17;2018:bcr2017223920. doi: 10.1136/bcr-2017-223920.

Movement Disorders and Neurometabolic Diseases

Christensen CK, Walsh L.

Semin Pediatr Neurol. 2018 Apr;25:82-91. doi: 10.1016/j.spen.2018.02.003. Epub 2018 Feb 14.

Huntington's disease: Current and future therapeutic prospects

Kieburtz K, Reilmann R, Olanow CW.

Mov Disord. 2018 Jul;33(7):1033-1041. doi: 10.1002/mds.27363. Epub 2018 May 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias